Unicycive Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for UNCY, updated each market day.
UNCY AI Sentiment
AI predicts Unicycive Therapeutics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Unicycive Therapeutics, Inc. Common Stock
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Sector
Exchange
Market Cap
$167,831,250
Cap Tier
Employees
22
Headquarters
LOS ALTOS, CA
Listed Since
July 13, 2021
Website
UNCY Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
UNCY Volatility
Unicycive Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
